This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

8 Stocks Rising on Big Volume

Impax Laboratories

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Impax Laboratories (IPXL - Get Report) is a technology-based, specialty pharmaceutical company focused on the development and commercialization of bioequivalent and brand-name pharmaceuticals. This stock is trading up 4.7% at $26.01 in recent trading.

Today's Volume: 816,000

Average Volume: 536,486

Volume % Change: 184%

>>5 Stocks With Big Insider Buying

From a technical perspective, IPXL is ripping higher here above-average volume, and its trending into breakout territory above some near-term overhead resistance levels at $25.31 to $25.36. At last check, IPXL has hit an intraday high of $26.08 and volume is well above its three-month average action of 536,486 shares.

Traders should now look for long-biased trades in IPXL as long as its trending above today's low of $24.75 with strong upside volume flows. I would consider any upside volume day that registers near or above 536,486 shares as bullish. If IPXL can hold that trend, and especially hold its trend above those breakout levels, then this stock has a great chance of re-testing or taking out its next major overhead resistance levels at $27 to $28.75 in the near future.
6 of 9

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AZO $765.23 0.00%
CTRP $43.61 0.00%
GM $31.80 0.00%
IPXL $33.35 0.00%
XXIA $10.12 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs